SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. New Engl J Med 2001; 345: 1098104.
  • 2
    Bergstrom L, Yocum DE, Ampel NM, Villanueva I, Lisse J, Gluck O, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists. Arthritis Rheum 2004; 50: 195966.
  • 3
    Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease [published erratum in Inflamm Bowel Dis 2005;11:705]. Inflamm Bowel Dis 2004; 10: 4367.
  • 4
    Velayos FS, Sandborn WJ. Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-α therapy with infliximab for Crohn's disease. Inflamm Bowel Dis 2004; 10: 65760.
  • 5
    Shatin D, Rawson N, Stergachis A. UnitedHealthGroup. In: StromB, editor. Pharmacoepidemiology. 4th ed. West Sussex: John Wiley & Sons; 2005.
  • 6
    Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004; 148: 99104.
  • 7
    West S, Strom B, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In: StromBL, editor. Pharmacoepidemiology. 4th ed. West Sussex: John Wiley & Sons; 2005.
  • 8
    Choquette D, Einarson T, Leombruno J. Opportunistic infections with anti-TNF agents: estimating incidence from pharmacy and physician claims databases. Arthritis Rheum 2005; 52: S34950.
  • 9
    Smitten A, Simon T, Hochberg M, Suissa S. Rates of infection in rheumatoid arthritis [abstract]. Arthritis Rheum 2004; 50: S4789.
  • 10
    Metlay J, Kinman J. Failure to validate pneumococcal pneumonia diagnoses in the general practice research database [abstract]. Pharmacoepidemiol Drug Saf 2003; 12: S1634.
  • 11
    Leveille SG, Gray S, Black DJ, LaCroix AZ, Ferrucci L, Volpato S, et al. A new method for identifying antibiotic-treated infections using automated pharmacy records. J Clin Epidemiol 2000; 53: 106975.
  • 12
    Sands K, Vineyard G, Livingston J, Christiansen C, Platt R. Efficient identification of postdischarge surgical site infections: use of automated pharmacy dispensing information, administrative data, and medical record information. J Infect Dis 1999; 179: 43441.
  • 13
    Yokoe DS, Coon SW, Dokholyan R, Iannuzzi MC, Jones TF, Meredith S, et al. Pharmacy data for tuberculosis surveillance and assessment of patient management. Emerg Infect Dis 2004; 10: 142631.